Omar Israel Albarran

Responsible for the accurate and compliant reporting of financial statements per US GAAP and local statutory requirements. This includes all accounting, treasury and internal control related matters performed locally or through partner teams. Acts as key contact for internal stakeholders across BSC, Global Consolidation, Payroll, Tax and Treasury to manage monthly closing, inventory & asset management, sales accounting, pension & benefits accounting, and treasury related activities.

Ensured alignment of MKT and commercial decisions with organizational policies by proving strategic financial support. Ascertained impact of risk and investments on the company’s profitability through in-depth analysis and clarification of the associated factors. Adhered to corporate guidelines while leading annual budget and forecasts. Elaborated on key factors responsible for the variances and implemented a robust risk mitigation plan.

Accomplished saving targets and ensured consistent year-on-year growth through the provision of a remarkable assistance for the annual budget and forecasting process along the year for the Human Health Division exclusive of the USA market only. Delivered high-end financial counsel to global finance and human resources leads for MSDi Region. Provided quality support during the preparation of the quarterly results with PwC aimed at elaborating organizational financial performance.

Ensured adherence of primary care business unit decision-making to company policies through comprehensive financial support. Achieved saving targets and consistent YOY growth by coordinating annual budget and forecasting process for the Global Human Health Division in compliance with regional guidance. Built and directed the FP&A & SAP implementation teams comprising two direct reports from the FP&A team and four Indirect reports for the efficacious management of the SAP Project.

Spearheaded annual budget and forecast cycle for MCC Division for North LatAm Cluster. Assessed and sorted risk and investments to ascertain potential impacts on profitability. Evaluated the profitability of the new launches, line extensions, and switches from Rx to OTC by conducting financial analysis. Created robust decks for analyzing results with Regional Committee alongside explaining key drivers of the variances in North LatAm Cluster for identifying risks and enacting the mitigation plan.